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Perry Hackett (University of Minnesota): Greg, what’s your take on Golden Rice, because 
you made a point that, so far, there’s nothing to benefit consumers versus the producers 
or farmers.
Gregory Jaffe: I was in the Philippines in July, visited IRRI1 and talked to some of the 
researchers. I saw some of the Golden Rice there. I don’t anticipate that there is any food-
safety risk from that and I don’t think there are any major environmental concerns. The 
bigger issues are how you get it into the proper communities and make sure they adopt 
it and use it in their diets. The most important thing is getting it into varieties that yield 
well and those farmers want to grow. The project seems to be moving forward, and it will 
be a benefit for those consumers. For consumers in the United States, some high-oleic-
oil soybean and other things are beginning to come out and those may be perceived by 
consumer as benefits, including my organization2. But, to date, most of the crops around 
the world have not been seen as beneficial.
Michael Kahn (Washington State University): A question for Jeff, but the others may 
want to comment too. With regard to risk, there is one smoking gun out there—that I am 
aware of—and that is the Showa Denko tryptophan nutritional supplement that caused 
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a lot of problems in the early 1980s. The supplement, sold over the counter, in some way 
generated high levels of neurotoxic compounds. They eventually settled and paid a lot of 
damages. The irony is that this is still a possibility, because nutritional supplements are 
not regulated by FDA, except after the fact. After the damage is done, you pull a harm-
ful compound off the market. So, with regard to Jeff, yes there could be risks out there, 
but the focus of the system on the process of getting to market as opposed to the risks 
that exist in the market—or the quality of the product—is a problem that is not being 
addressed. Would you comment on that, from the standpoint of risk?
Jeff Wolt: I will try to. I think you are saying that we need to be cautious. We cannot 
be cavalier in our approach to these products as they come to the market. You pointed 
out a good example of where, from a societal standpoint, with our process focus we 
are missing the perspective of what we are responsible for in seeking out risk. Why do 
we look so closely at genetically engineered crops when food supplements are largely 
ignored? There’s a disconnect within our regulatory process. It’s due to the complexity 
in the way we regulate things and the fact that they are dispersed over so many agencies 
and subparts of agencies. We need to always be open to the potential for risks, but we 
are so often constrained by the regulatory remits within our governmental agencies that 
we misdirect our attention.
Brian Larkins (University of Nebraska): I’ll preface this by saying that I am not an econo-
mist and I’m not a sociologist. I am ignorant of a lot of things, but it strikes me that we 
need a new strategy. It might be simpler just to label things. Many things appear on labels 
on packages and for the kinds of ingredients that we are talking about—principally corn, 
soy, and maybe cotton—they are refined products. Why not just put something on there 
such as, This food contains ingredients from genetically modified crops that are generally recog-
nized as safe? I think that, within a very short time, consumers who bother to read labels 
would not be so concerned. Is the cost of not labelling worth what we are paying in terms 
of regulation and delay in future technologies that could be very useful to society?
Wolt: This is problematic for me because, as a risk assessor and scientist, I have long ad-
hered to FDA’s position that the information on food labels should have a bearing with 
regard to consumer safety. They are not always able to do that, but the intent is to label in 
that way. Once we open the floodgates and allow information on the label that is broader 
than safety, we distract the consumer and we weaken the strength of the label. However, 
I do have mixed feelings on this because labeling of GM foods has been reshaped by the 
protest industry over time, from a science issue to a choice issue. All of us are sympathetic 
to the idea of choice, and so, having labeling as a choice issue, tends to resonate. On the 
other hand, I’m afraid that labeling and the advent of labeling—which I believe is going 
to happen—won’t be the last salvo in this war. It will be just one step along the way. Those 
who are aligned against GM technology and foods derived from GM crops will simply 
use it as the next step in their campaign to denigrate and stigmatize this technology.
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Drew Kershen: I think they are quite distinct issues. Labelling really has no impact on 
the regulatory system as a practical matter. Labeling laws are not going to affect, in any 
way, the ability to move these crops to market in a quicker or more efficient or less costly 
way. In Europe, the advent of labeling meant that the processor simply stopped access-
ing any food that had an ingredient that required the food to be labeled, and it has had 
a tremendously detrimental impact. It was perceived to be a worry about loss of market 
and a worry about stigma. I think the United States would likely be very similar to that; 
it would be used by the protest industry as a way of stigmatizing and a way of then mak-
ing certain that it was a market-share issue. Of course, you can do this anyway in terms 
of pressure. You may know that there is pressure on all sorts of food companies to drop 
ingredients that come from genetically modified crops or genetically modified animals. 
And so, it’s unlikely to solve anything and I agree with Jeff that it would be used as an-
other hammer to stigmatize agricultural biotechnology. Food companies are very worried 
about that. There are several issues along that same line. You could consider trade issues in 
similar fashion. The issue is what would be the impact on these crops? The protest industry 
is intent on using this to drive agricultural biotechnology out of the market, by making 
it impossible to sell these foods. That’s their goal. That’s what they want to do. That is 
why they are labeling. They are allied with the organic industry, which sees this as a way 
of increasing their market share significantly. With those two allies doing that, I don’t 
favor labeling. Along the lines Jeff has said, what is the purpose of the label? The goal is to 
provide effective, clear information to consumers so that they have safe foods.
Jaffe: I agree with Jeff and Drew. At CSPI, we don’t support mandatory government-
imposed labels except in situations where a safety or nutritional issue dictates it. Labeling 
shouldn’t be a surrogate for safety; if there is an issue of safety we should have a regulatory 
process to determine that the food is safe before it goes into the supermarket. As a parent, 
I want to know that everything in the supermarket is safe to eat. I can then choose among 
different labeled foods for different philosophies or religion or other reasons I have, but I 
don’t say, “We’re not going to have a regulatory process, but we’ll label it and people can 
choose whether or not they want to eat it, whether they think it is safe or not.” I don’t 
think that is the proper public policy. With that in mind, though, I do advocate to all in 
the food chain that transparency is very important. Consumers have a point when they 
ask, “If this is safe why are you hiding it from me?” Whether it’s voluntary labeling on the 
package, or it’s on a website on the internet, or it’s in a barcode you can read with your 
smartphone,  I do think that, for the person who wants the information, it shouldn’t be 
hidden. One way forward is better transparency.
Kershen: Let me add to that. Transparency might in fact work the way Greg has just 
described it, if, in fact, we are willing to be transparent about the reality of genetically 
modified organisms. For example, we would have to drop the distinctions Europe makes 
between a food made with a GMO and a food made from a GMO, and that prepositional 
difference matters tremendously. A food made from requires a label. A from food is, for 
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example, a canola oil that has no trace of the transgenic DNA or chemistry. That has to 
be labeled because it’s from. However, many cheeses, and wines are made with enzymes 
that are genetically modified. The leading enzyme company in the world is Novozymes of 
Denmark, which produces many enzymes and if you were to label every food produced 
with those enzymes, it would be almost 100% and then it would become irrelevant.
Steve Pueppke: We’ve had good discussion on this. Let’s try to get a couple more ques-
tions in.
Tom Turpen (Citrus Research and Development Foundation): I’d like the panel to continue 
to throw out ideas on how to reframe the discussion for public opinion, because that seems 
to be so key to regulatory reform. It has two parts. First, who is the voice? Who speaks for 
this? I think the NABC has a unique role to play, particularly if on the same page with 
the NRC study that is in process. The National Academy, the USDA and NABC would 
provide a powerful voice. But then, you still have to address the content. What positive 
content will sway public opinion? For citrus greening, we need a sustainable solution and 
it’s got to be genetic in the long term. However, it’s not at all clear who is going to pay for 
tree replacement. It’s not just the public sector that is priced out of that equation. It’s also 
the private sector. That’s bad enough for seed crops, but for permanent crops it doesn’t 
make financial sense which means it won’t get done. This means that food is going to be 
more scarce and more expensive, and yet cost always seems to be way down the list of 
anyone’s themes to talk about. I want to hear ideas about how to communicate for public 
opinion with positive themes that are going to resonate. We need an anti-Frankenfood 
poster; what is the counter opinion that is equally effective to that messaging? We have 
poverty and hunger in our country too. It’s not just a developing-world problem. Why 
isn’t that part of the discussion?
Jaffe: Citrus greening, if that ends up being a genetically engineered solution will be 
viewed as a tremendous consumer benefit, if it is properly presented to the public. The 
major question, when you are talking about this technology is, “Why are you doing this?” 
People haven’t talked about cost because these are commodity crops, and the cost of the 
cornflakes in the box isn’t relevant. I think if consumers have the choice of American 
orange juice versus Brazilian orange juice and Brazilian orange juice is twice as expensive, 
I think they will choose American orange juice—no question about that. In addition to 
cost, they care about “American.” A new thing now is labeling things that are not imported. 
Nobody wants stuff from China and that’s another selling point. Properly answering why 
are you doing this is important for the public because many suspect that somebody is tin-
kering with something because they can do it rather than for a good reason. Secondly is 
the public aspect of it. If things are done by a multinational corporation, consumers are 
more hesitant than if they are done by a small company or by a public university. I was 
sorry when everybody was saying we’re going to do the public stuff but then we are goingto 
license the IP to the big companies. I think that is not advantageous. Why not license to 
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some small companies? I think that small companies may be perceived differently. And 
the third thing I’d mention is education, such as provided by NABC members: education 
about agriculture in general. Where does our food come from? I think most Americans 
are like me; I grew up in the suburbs of New York City and now I live in the suburbs of 
Virginia, far away from farms. Many consumers don’t understand what scientists do for 
agriculture and what farmers do and what their work involves. One of my suggestions was 
going to be put things in context, but the public has the context of “Old McDonald had a 
farm” and everything else sounds scary by comparison.  Context is really important.
B.J. Haun (Cellectis Plant Sciences): An interesting thing was brought up by Drew about 
USDA having an exempt category, and an interesting point was made about people think-
ing that the ruby red grapefruit is organic. There’s a double-edged sword there which I 
would like the panel’s opinion on. If you make these exempt categories you would actu-
ally reduce transparency, whereas transparency is what allowed the ruby red grapefruit to 
be considered natural. Going down the path of listing exempt categories, is that a good 
thing or a bad thing? Is that going to make certain things that industry and the public 
sector make more readily received? Will less transparency give the NGO’s even more 
ammunition against us?
Kershen: The theory has been that if the government regulates it, people have confidence 
in it. I think that that has been proven incorrect. You regulate because it’s not safe and 
you are dealing with safety. So, there is no need to regulate when there is not a safety 
issue. In fact, to do so miss-educates the public, miss-educates them in a fundamental 
way because it is really against transparency. It’s like the headlines you get on the internet; 
many are simply incorrect and biased. So, I think the answer is, we’ve gone down that 
route, it’s been tested, it’s been proven that if you regulate that, in fact, you are giving the 
wrong message, you educate the public incorrectly. Therefore, one way to deal with this 
is, in fact, to say, “It’s time to change the regulatory paradigm.”
Donald Weeks (University of Nebraska): Greg, you indicated that you thought that there 
could be a chance for redoing the regulatory system. Some of us are of the opinion that, 
once the regulatory system has been put in place, it’s not going to be displaced because of 
its—I don’t know the right word to use—it’s permanency. Are there chances for redoing 
the regulatory system, or are we fantasizing if we think about that?
Jaffe: Changing regulatory systems is tough to do, but it does happen. The Food Safety 
Modernization Act was signed into law in 2011 to revise what were outdated food-safety 
laws and to change the power that FDA has and how they regulate different things, with 
emphasis on produce, which was causing lots of outbreaks, and less emphasis on other 
things that weren’t causing outbreaks but were maybe covering food-safety problems in 
the 1950s. Whether that’s likely to happen in the immediate future for biotech, I’m not 
sure there is sufficient interest. But, I think it would be better.
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Wolt: A quick word of caution—be careful what you wish for. I think that most of us 
who deal in regulatory-related arenas are cautious in encouraging change in regulations, 
because you really don’t know what the repercussions are going to be down the road. It 
might be better to live with what you’ve got than to wish for a new day. The Food Quality 
Protection Act is a good example. There was a big push by a lot of parties to move that 
through to, essentially, update our regulatory approach to pesticides, and unintended 
consequences have made things somewhat more difficult in terms of our ability to use 
modern chemical pesticides. So, I think there is an opportunity to change regulations, 
but what you wish for and what you get may be two different things.
Pueppke: Let’s give Mike Kahn the last question.
Kahn: With regard to changing the regulatory climate, one can go back a few years to 
the Delaney Amendment, which was aimed at keeping all cancer-causing compounds 
out of food. However, with improvements in analytical technologies, it turns out that 
cancer-causing compounds are in all food at some level. And so, that particular regulatory 
paradigm had to be broken because it didn’t make any sense. In fact, it was essentially 
redefined as there’s a minimum kind of background, cosmic rays or something like that, that 
creates a hazard and you are not going to get below that. You shouldn’t be regulating to the 
nth degree when there are these other things present. Somebody pointed out that some of 
the results of this editing technology are indistinguishable from natural mutations. If you 
knock four bases out of a promoter, you can’t tell whether that was done with CRISPR 
or TALEN or a zinc-finger nuclease or it just happened to a plant that was growing out 
in the field. We are getting to the point where this kind of product distinction makes no 
sense—to distinguish recombinant DNA from natural products. I think there is a need 
for redefinition to incorporate that kind of realization.
Kershen: I agree, but I don’t think that the law will necessarily make the same distinc-
tion that you just made. And I say that because when you look at the EU regulations, 
particularly regulation 1830/2003 on labeling and traceability, it requires that anything 
that meets the definition of genetic modification—even though it is not in the final prod-
uct—you’ve got to provide a paper trail for labeling purposes. If you use a technique that 
is regulated within that system, the fact that you won’t be able to detect it at the end will 
be irrelevant because the food people and the food developers who put this on the market 
are required to provide a paper trail that comes with an enforcing mechanism with both 
civil and criminal penalties. As a lawyer, I would be very adverse to advising my client 
they’ll never find it because, I guarantee you, there are NGOs who are looking every day 
to find it to punish you and they will find it, in which case I’ll be in the European court 
with my client. I have a theory about representing clients: they go to jail, I go home. I’ll 
be trying to keep my client out of jail, but if I fail, I’ll say, “I hope you find good wine 
in your French cell.”
